Thrombin activable fibrinolysis inhibitor (TAFI): molecular genetics of an emerging potential risk factor for thrombotic disorders.

Current drug targets. Cardiovascular & haematological disorders

Volumn 1, Issue 2, 2001, Pages 59-74

  Boffa, M B ^a   Nesheim, M E ^a   Koschinsky, M L ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR;

ANIMAL; CHEMISTRY; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; REVIEW; RISK FACTOR; THROMBOSIS;

ANIMALS; CARBOXYPEPTIDASE U; HUMANS; RISK FACTORS; THROMBOSIS;

EID: 0010090951     PISSN: 15680061     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568006013337999     Document Type: Review

References (90)